Laquinimod
Product Specifications
CAS Number
248281-84-7
Target
Apoptosis, NF-κB
Related Pathways
Apoptosis, NF-κB
Purity
0.9884
Bioactivity
Laquinimod (LAQ) is an effective immunomodulator, which is currently under development in phase III trials for the treatment of multiple sclerosis as an oral therapy.
Smiles
CCN(C(=O)c1c(O)n(C)c2cccc(Cl)c2c1=O)c1ccccc1
Molecular Formula
C19H17ClN2O3
Molecular Weight
356.8
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1380604-01 0.02 mg (E-Coli)
Recombinant Brucella abortus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Sign In for Pricing
View Details MBS1380604-02 0.02 mg (Yeast)
Recombinant Brucella abortus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Sign In for Pricing
View Details MBS1380604-03 0.1 mg (E-Coli)
Recombinant Brucella abortus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Sign In for Pricing
View Details MBS1380604-04 0.1 mg (Yeast)
Recombinant Brucella abortus UDP-N-acetylenolpyruvoylglucosamine reductase (murB)
Sign In for Pricing
View Details